Precision Population-Based Screening for Glaucoma

Glaucoma is the leading cause of irreversible blindness globally, and efforts are ongoing across the field of ophthalmology to facilitate early detection and treatment for this optic neuropathy, which can be insidious and asymptomatic in its early and moderate stages.Much focus has been dedicated to identifying high-risk populations due to concern for underidentification and subsequently undertreatment.Frediani et al 1 examined a complementary concern of overidentifying or overreferring low-risk populations.The authors analyzed retrospective data from a large, diverse managed care population in Southern California to better understand referral patterns among adults (aged 18 to 40 years), presenting for first-time eye examinations.By modeling data across a 5-year period, some key findings from their study were that (1) the diagnostic yield of glaucoma referrals in this population of adults aged 18 to 40 years was low, (2) a simple 3-variable model consisting of age, intraocular pressure, and cup-disc ratio may have risk stratified patients and yielded a high negative predictive value, and (3) racial and ethnic disparities existed regarding loss to follow-up for glaucoma referrals even among an insured population.Population-based glaucoma screening has not been strongly supported by public health guidelines in the US.For example, in 2013, the US Preventive Services Task Force determined that the evidence "was insufficient to assess the balance of benefits and harms of screening for primary open angle glaucoma in adults," with the most recent update in evidence conducted in 2022, which did not change this assessment. 2However, there are increasing conversations and advocacy among the ophthalmologic community in favor of population-based screening for glaucoma, particularly for high-risk populations.These are well-described in a series of articles recently featured in a Journal of Glaucoma supplement. 3Many population-based screening programs across medicine are aimed at

Authors

Institutions

Publication Details

Journal
JAMA Network Open
Published
2025-02-06
DOI
https://doi.org/10.1001/jamanetworkopen.2024.57849
Citations
1
Primary Topic
Glaucoma and retinal disorders
Type
article
Field-Weighted Citation Impact
1.71
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Precision Population-Based Screening for Glaucoma

Sally L. Baxter
1 citations
JAMA Network Open
Glaucoma and retinal disorders
1.71
article

Precision Population-Based Screening for Glaucoma

Sally L. Baxter
article en
1 citations

Abstract

Glaucoma is the leading cause of irreversible blindness globally, and efforts are ongoing across the field of ophthalmology to facilitate early detection and treatment for this optic neuropathy, which can be insidious and asymptomatic in its early and moderate stages.Much focus has been dedicated to identifying high-risk populations due to concern for underidentification and subsequently undertreatment.Frediani et al 1 examined a complementary concern of overidentifying or overreferring low-risk populations.The authors analyzed retrospective data from a large, diverse managed care population in Southern California to better understand referral patterns among adults (aged 18 to 40 years), presenting for first-time eye examinations.By modeling data across a 5-year period, some key findings from their study were that (1) the diagnostic yield of glaucoma referrals in this population of adults aged 18 to 40 years was low, (2) a simple 3-variable model consisting of age, intraocular pressure, and cup-disc ratio may have risk stratified patients and yielded a high negative predictive value, and (3) racial and ethnic disparities existed regarding loss to follow-up for glaucoma referrals even among an insured population.Population-based glaucoma screening has not been strongly supported by public health guidelines in the US.For example, in 2013, the US Preventive Services Task Force determined that the evidence "was insufficient to assess the balance of benefits and harms of screening for primary open angle glaucoma in adults," with the most recent update in evidence conducted in 2022, which did not change this assessment. 2However, there are increasing conversations and advocacy among the ophthalmologic community in favor of population-based screening for glaucoma, particularly for high-risk populations.These are well-described in a series of articles recently featured in a Journal of Glaucoma supplement. 3Many population-based screening programs across medicine are aimed at

JAMA Network OpenVol. 8(2)
University of California San Diego (US)
Zero hunger
Openalex Percentile: Top 22%
Glaucoma and retinal disorders
1.71
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.